Early phase combined therapeutic management of acute ischaemic stroke

Neurological Sciences

Volumn 26, Issue SUPPL. 1, 2005, Pages

  Bassi, Pietro ^a   Lattuada, P ^a   Tonietti, S ^a  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Acute phase; Cerebral ischaemia; Stroke unit; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; INSULIN; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; NITROPRUSSIDE SODIUM; OXYGEN;

ACUTE DISEASE; ADJUVANT THERAPY; ARTICLE; BLOOD OXYGENATION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; EARLY DIAGNOSIS; HEART DISEASE; HEMODYNAMIC PARAMETERS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTHERMIA; INTERDISCIPLINARY COMMUNICATION; OXYGEN THERAPY; PATIENT MONITORING; PREDICTION; PSYCHOLOGIC ASSESSMENT; SEIZURE; TREATMENT OUTCOME;

ACUTE DISEASE; BRAIN ISCHEMIA; EMERGENCY TREATMENT; FIBRINOLYTIC AGENTS; HUMANS; REHABILITATION; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 18344367655     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-005-0400-1     Document Type: Article

References (5)

1. Stroke Unit Trialists' collaboration (2003) Organized inpatient (Stroke Unit) care for stroke (Cochrane Review). In: The Cochrane Library, Issue 1. Update Software, Oxford
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587
3. International Stroke Trial Collaborative Group (1997) The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 195435 patients with acute ischemic stroke. Lancet 349:1569-1581
4. Powers WJ (1993) Acute hypertension after stroke: The scientific basis for treatment decisions. Neurology 43:461-467
5. Bruno A, Biller J, Adams HP, Clarke WR, Woolson RF, Williams LS, Hansen MD (1999) Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 52:280-284